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Summary
To establish an infection, the pathogen 
 
Candida albi-
cans
 
 must assimilate carbon and grow in its mamma-
lian host. This fungus assimilates six-carbon
compounds via the glycolytic pathway, and two-
carbon compounds via the glyoxylate cycle and glu-
coneogenesis. We address a paradox regarding the
roles of these central metabolic pathways in
 
C. albicans
 
  pathogenesis: the glyoxylate cycle is
apparently required for virulence although glyoxylate
cycle genes are repressed by glucose at concentra-
tions present in the bloodstream. Using GFP fusions,
we conﬁrm that glyoxylate cycle and gluconeogenic
genes in 
 
C. albicans
 
 are repressed by physiologically
relevant concentrations of glucose, and show that
these genes are inactive in the majority of fungal cells
infecting the mouse kidney. However, these pathways
are induced following phagocytosis by macrophages
or neutrophils. In contrast, glycolytic genes are not
induced following phagocytosis and are expressed in
infected kidney. Mutations in all three pathways atten-
uate the virulence of this fungus, highlighting the
importance of central carbon metabolism for the
establishment of 
 
C. albicans
 
 infections. We conclude
that 
 
C. albicans
 
  displays a metabolic program
whereby the glyoxylate cycle and gluconeogenesis
are activated early, when the pathogen is phagocy-
tosed by host cells, while the subsequent progression
of systemic disease is dependent upon glycolysis.
Introduction
 
Candida albicans
 
 is the major systemic fungal pathogen
of humans. This fungus exists as a relatively harmless
commensal in the oral cavity and gastrointestinal tracts of
most individuals, but when the defences of the host
become compromised, it can cause mucocutaneous
infections such as oral or vaginal candidiasis (Odds, 1988;
Calderone, 2002). In severely immunocompromised indi-
viduals, 
 
C. albicans
 
 can establish deep-seated systemic
infections, which in some patient groups are often fatal
(Odds, 1988; Calderone, 2002). Bloodstream infections
are thought to arise by two major routes: through pene-
tration of mucosal surfaces, or via intravascular catheters
(Velasco 
 
et al
 
., 2000; Kullberg and Oude Lashof, 2002),
and the formation of 
 
C. albicans
 
 bioﬁlms upon catheters
can exacerbate the infection source (Douglas, 2003). In
the absence of effective immune defences, 
 
C. albicans
 
can then disseminate via the bloodstream and colonize
internal organs such as the kidney.
To grow, a microbe must assimilate carbon. Pathogens
such as 
 
C. albicans
 
, which can thrive within diverse niches
such as the skin, mucous membranes, blood and internal
organs of its human host and in bioﬁlms (Odds, 1988;
Calderone, 2002), must display sufﬁcient metabolic ﬂexi-
bility to assimilate the available nutrients in these niches.
Data from several transcript proﬁling studies are consistent
with this notion (reviewed in Brown, 2005). For example,
amino acid biosynthetic genes are upregulated in
 
C. albicans
 
  cells growing in bioﬁlms (Garcia-Sanchez
 
et al
 
., 2005). Also, following exposure to human neutro-
phils or cultured macrophages, 
 
C. albicans
 
  populations
upregulate amino acid biosynthetic genes and display a
shift from fermentative to non-fermentative metabolism
(Rubin-Bejerano 
 
et al
 
., 2003; Lorenz 
 
et al
 
., 2004; Fradin
 
et al
 
., 2005). This includes the downregulation of glycolytic
genes and the activation of glyoxylate cycle genes (
 
ICL1,
MLS1
 
), which facilitate the assimilation of two-carbon
compounds in concert with gluconeogenic genes (
 
PCK1,
FBP1
 
). Further evidence for the activation of glyoxylate
cycle genes following exposure to macrophages has been
obtained by differential display reverse transcription poly-
merase chain reaction (PCR) (Prigneau 
 
et al
 
., 2003).
Lorenz and Fink (2001) have shown that 
 
C. albicans
icl1/icl1
 
 mutants display attenuated virulence in the mouse
model of systemic candidiasis. This has led to the sug-
gestion that the glyoxylate cycle is required for fungal
virulence (Lorenz and Fink, 2001; 2002). However in 
 
Sac-
charomyces cerevisiae
 
, gluconeogenic and glyoxylate
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cycle genes are exquisitely sensitive to glucose (Yin 
 
et al
 
.,
2003). These genes are repressed by glucose at concen-
trations as low as 0.01%, which are well below those
present in the bloodstream (3–5 mM, which is equivalent
to about 0.06–0.1% glucose). If 
 
C. albicans
 
  gluconeo-
genic and glyoxylate cycle genes are regulated in an
analogous fashion to those in 
 
S. cerevisiae
 
, which is often
presumed to be the case, one would expect them to be
repressed during systemic infections. How then is the
glyoxylate cycle is required for the establishment of sys-
temic 
 
C. albicans
 
 infections?
To address this apparent paradox, we have revisited the
role of the glyoxylate cycle in 
 
C. albicans
 
 virulence. Fur-
thermore, we have extended this analysis to examine the
glycolytic and gluconeogenic pathways. In this study we
used GFP fusions, rather than transcript proﬁling, to mon-
itor gene activity (Barelle 
 
et al
 
., 2004). This was done for
three main reasons. First, transcript proﬁling averages the
behaviour of potentially heterogeneous cell populations,
whereas the use of GFP fusions has allowed us to examine
the behaviour of individual 
 
C. albicans
 
 cells within complex
niches. Second, this approach has allowed us to extend
our analyses beyond the 
 
in vitro
 
 and 
 
ex vivo
 
 models that
have been used for transcript proﬁling, to monitor gene
expression levels in the mouse model of systemic candid-
iasis. Third, while transcript proﬁling has indicated whether
genes are up- or downregulated (by generating expression
ratios), our GFP approach has revealed interesting differ-
ences in the absolute expression levels for speciﬁc gene
fusions. All three factors have proved important in describ-
ing the behaviour of this pathogenic fungus 
 
in vivo
 
. Taken
together with our phenotypic analysis of metabolic null
mutants, our GFP studies suggest that 
 
C. albicans
 
 differ-
entially regulates its central pathways of carbon assimila-
tion at different stages and sites of disseminated infections.
 
Results
 
Regulation of glycolytic, gluconeogenic and glyoxylate 
cycle genes in vitro
 
Promoter–GFP fusions were constructed to monitor the
regulation of glycolytic, gluconeogenenic and glyoxylate
cycle genes in 
 
C. albicans
 
 (Fig. 1). Most of the enzymes
on the glycolytic pathway catalyse reversible reactions
that also contribute to gluconeogenesis. However, two
steps in glycolysis are essentially irreversible and these
are catalysed by the glycolysis-speciﬁc enzymes, phos-
phofructokinase and pyruvate kinase. 
 
PFK2
 
 encodes one
of two phosphofructokinase subunits, and 
 
PYK1
 
 encodes
pyruvate kinase. 
 
PCK1
 
  encodes the gluconeogenenic-
speciﬁc enzyme, phosphoenolpyruvate carboxykinase.
 
ICL1
 
  encodes the glyoxylate cycle enzyme, isocitrate
lyase (Fig.  1). Therefore, the 
 
PFK2, PYK1, PCK1
 
  and
 
ICL1
 
 promoter regions were cloned upstream of the yeast
enhanced GFP (yEGFP) gene in the vector pGFP, and
these plasmids were stably integrated at the 
 
RPS1
 
 locus
in the 
 
C. albicans
 
 genome. The genotype of these strains
was conﬁrmed by diagnostic PCR and Southern blotting
(not shown).
The expression patterns of these promoter fusions were
ﬁrst examined 
 
in vitro
 
.  To  achieve this, we grew the
 
C. albicans
 
 strains on different carbon sources and mea-
sured the mean GFP ﬂuorescence per cell. As expected
(Leuker 
 
et al
 
., 1997; Lorenz and Fink, 2001; Murad 
 
et al
 
.,
2001), the 
 
PCK1-
 
 and 
 
ICL1-GFP
 
 fusions were expressed
during growth on amino acids and repressed during
growth on glucose  (Fig. 2A). The 
 
PCK1
 
 and 
 
ICL1
 
 fusions
displayed similar expression patterns in yeast and hyphal
cells (not shown). Interestingly, these 
 
C. albicans
 
 genes
were sensitive to low glucose concentrations, like their
homologues in 
 
S.  cerevisiae
 
  (Yin 
 
et al
 
., 2003). Signiﬁ-
cantly, the 
 
PCK1
 
  and 
 
ICL1
 
  fusions were repressed at
physiologically relevant glucose concentrations (0.1%),
implying that the gluconeogenic pathway and the glyoxy-
late cycle are inactive under these conditions (Fig. 2B).
The 
 
PFK2-
 
 and 
 
PYK1-GFP
 
 gene fusions, which were
designed to monitor glycolytic activity, were expressed at
low levels following protracted growth on non-fermentative
growth media containing amino acids as sole carbon
 
Fig. 1.
 
Cartoon of central carbon metabolism, highlighting the steps 
analysed in this study.
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source (Fig.  2A). However, both fusions were activated
when 
 
C. albicans
 
  cells resumed growth after stationary
phase, irrespective of whether amino acids or glucose
was available as sole carbon source (Fig. 2C). The 
 
PFK2
 
and 
 
PYK1
 
 fusions displayed similar expression patterns
in yeast and hyphal cells (not shown). We conclude that
 
PFK2-
 
 and 
 
PYK1-GFP
 
 expression reﬂects active growth
of 
 
C. albicans
 
 rather than glycolytic activity 
 
per se
 
.
To test whether the behaviour of these promoter fusions
reﬂected the expression of the native proteins, we exam-
ined the expression levels of the Pfk2, Pyk1, Pck1 and
Icl1 proteins during the growth of 
 
C. albicans
 
 in the pres-
ence or absence of glucose. This was done as part of a
global proteomics study of 
 
C. albicans
 
  (in preparation:
http://www.abdn.ac.uk/cogeme). The glycolytic enzymes,
Pfk2 and Pyk1, were expressed at roughly equivalent
levels during exponential growth in the presence or
absence of glucose (not shown). In contrast, the expres-
sion of the Pck1 and Icl1 proteins was repressed by glu-
cose. These proteins were not detected during growth on
glucose. Also, Pck1 expression levels decreased about
threefold within 2 h of 0.1% glucose addition to cells grow-
ing on amino acids or lactate as sole carbon source (not
shown). Therefore, the behaviour of the 
 
PFK2-, PYK1-,
PCK1-
 
  and 
 
ICL1-GFP
 
  fusions accurately reﬂected the
expression of the native enzymes.
 
Differential expression of glycolytic, gluconeogenic and 
glyoxylate cycle genes in 
 
ex vivo
 
 models
 
Having established the expression patterns of the 
 
PYK1,
PFK2, PCK1
 
 and 
 
ICL1
 
 fusions 
 
in vitro
 
, we examined their
behaviour in two medically signiﬁcant 
 
ex  vivo
 
  models.
Neutrophils and macrophages represent ﬁrst lines of
innate host defence when 
 
C. albicans
 
 cells infect the blood-
stream or endothelia respectively. Neutropenic patients are
 
Fig. 2.
 
Differential 
 
in vitro
 
 regulation of glycolysis, gluconeogenesis and the glyoxylate cycle in 
 
C. albicans
 
.
A. 
 
C. albicans
 
 strains containing 
 
PFK2-, PYK1-, PCK1-
 
 and 
 
ICL1-GFP
 
 promoter fusions or the empty pGFP control (CJB-1, CJB-2, CJB-3, CLM1-
1, CLM3-2: Table 1) were examined after growth overnight on minimal media containing 2% glucose (Glu) or 2% casamino acids (AAs) as sole 
carbon source. Merged GFP and DAPI images are shown alongside the corresponding light micrographs. Scale bar represents 10 
 
µ
 
m.
B. Repression of 
 
PCK1-
 
 and 
 
ICL1-GFP
 
 by different concentrations of glucose (mean GFP ﬂuorescence intensity per cell).
C. Quantiﬁcation of mean GFP ﬂuorescence levels for 
 
C. albicans
 
 cells with 
 
PFK2-
 
 and 
 
PYK1 -GFP
 
 fusions resuming growth on glucose or amino 
acids: cells grown overnight on amino acids (start); cells grown for 2 h on glucose (Glu) or amino acids (AAs). 
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especially susceptible to bloodstream candidaemias (Abi-
Said 
 
et al
 
., 1997). Transcript proﬁling has revealed that
glyoxylate cycle genes are induced in 
 
C. albicans
 
  cells
following exposure to neutrophils or macrophages (Lorenz
 
et al
 
., 2004; Fradin 
 
et al
 
., 2005). Therefore, we proﬁled
single 
 
C. albicans
 
 cells under similar conditions  (Fig. 3).
The 
 
C. albicans
 
 strains were exposed to primary human
neutrophils or cultured murine J774A-1 macrophages, and
the expression in phagocytosed fungal cells was compared
with the expression in non-phagocytosed cells (ratio of
mean GFP ﬂuorescence per fungal cell).
Three important observations were made. First, the
induction of 
 
ICL1-
 
 and 
 
PCK1-GFP
 
 was dependent upon
the internalization of fungal cells by neutrophils or mac-
rophages, and was not observed in non-phagocytosed
cells. In contrast, the glycolytic gene fusions were
expressed both inside and outside the neutrophils and
macrophages, and no signiﬁcant induction was observed
following phagocytosis. These observations are consis-
tent with transcript proﬁling experiments which have sug-
gested that glyoxylate cycle and gluconeogenic genes are
induced following phagocytosis. However, these studies
were unable to distinguish unambiguously between
phagocytosed and non-phagocytosed cells within hetero-
geneous populations (Lorenz 
 
et al
 
., 2004; Fradin 
 
et al
 
.,
2005). Second, GFP expression levels were generally an
order of magnitude higher following phagocytosis by neu-
trophils, compared with macrophages (Fig. 3). This differ-
ence is probably attributable to differences in transcription
because 
 
in vitro
 
 experiments have show that GFP stability
remains unaffected following exposure of 
 
C. albicans cells
to an oxidative stress (5 mM H2O2) or low pH (pH 4) (not
shown). These data add to the available transcript proﬁling
data, which did not provide information about absolute
expression levels in phagocytosed cells (Lorenz et al.,
2004; Fradin et al., 2005). Our data are consistent with
the idea that genes involved in central carbon metabolism
are more active in C. albicans cells engulfed by neutro-
phils, although neutrophils are thought to be more potent
than macrophages at killing fungal cells (Fradin et al.,
2005). Third, PCK1-GFP  expression levels were repro-
ducibly lower than ICL1-GFP  expression levels after
phagocytosis by neutrophils (Fig. 3A). This suggests that
glyoxylate cycle activity might not always be associated
with gluconeogenesis. It is possible that, in some body
sites, C. albicans cells might exploit the glyoxylate cycle
for the generation of metabolic intermediates rather than
hexose anabolism.
Differential expression of glycolytic, gluconeogenic and 
glyoxylate cycle genes during systemic infections
Having characterized the behaviour of the PFK2-, PYK1-,
PCK1-  and  ICL1-GFP  fusions  in vitro  and  ex  vivo, we
analysed their expression in vivo in the mouse model of
disseminated Candida infection  (Fig. 4). The C. albicans
strains were used to establish infections in immunocom-
petent mice, and the GFP ﬂuorescence examined in the
infected kidneys, as described previously (Barelle et al.,
2004). The PFK2-  and  PYK1-GFP  fusions were
expressed in nearly all of the fungal cells infecting these
kidneys, indicating that most C. albicans  cells were
actively growing in the infected tissue, or at least had been
growing shortly before the tissue was harvested and ﬁxed.
In contrast, of the thousands of fungal cells we examined
in infected kidneys, only about half expressed ICL1-GFP,
and about one-third expressed PCK1-GFP.  Two signiﬁ-
cant conclusions can be drawn from these observations.
First, it is clear that the population of fungal cells infecting
the kidney is highly heterogeneous, suggesting that indi-
vidual fungal cells occupy subtly different micro-environ-
ments and are exposed to different environmental signals
within the kidney. Second, only about third of C. albicans
cells infecting the kidney appear to assimilate carbon via
gluconeogenesis. The analysis of the PFK2- and PYK1-
GFP  fusions suggested that these cells were actively
growing (or had been very recently). Therefore, by infer-
ence, most C. albicans cells growing in the kidney were
assimilating carbon via glycolytic metabolism. This did not
seem consistent with the observation that the glyoxylate
cycle is required for C. albicans  virulence (Lorenz and
Fink, 2001).
Virulence of C. albicans null mutants with blocks in 
glycolysis, gluconeogenesis or the glyoxylate cycle
Lorenz and Fink (2001) reported that C. albicans icl1/icl1
mutants display attenuated virulence in the mouse model
of systemic candidiasis. However, after their article was
published it was shown that URA3 position effects can
inﬂuence the outcome of such virulence assays (Sund-
strom  et al., 2002; Brand et al., 2004; Sharkey et al.,
2005). As the URA3 marker was used to generate the icl1/
icl1 mutant, it was conceivable that the virulence of this
mutant was attenuated by the position of the URA3 at the
icl1  locus, rather than the disruption of the ICL1  gene
itself. Therefore, we re-evaluated the effect of inactivating
ICL1  upon  C. albicans  virulence. Having generated a
homozygous  icl1/icl1  mutant in C. albicans  RM1000 by
standard procedures (Wilson et al., 1999), we reintro-
duced the URA3 and HIS1 markers back into the mutant
through integration at the RPS1  locus via the vector,
CIp20. CIp20 is derived from CIp10 (Dennison et al.,
2005), which has been shown to circumvent URA3 marker
position effects (Brand et al., 2004). In addition, we
extended this work by generating congenic pck1/pck1 and
pyk1/pyk1  null mutants with a view to determining the
impact of these mutations upon C. albicans virulence.Regulation of carbon assimilation by C. albicans 965
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Fig. 3. Differential regulation of PFK2-, PYK1-, 
PCK1- and ICL1-GFP fusions in C. albicans 
following phagocytosis by (A)neutrophils or (B) 
macrophages.
A. C. albicans cells were mixed with primary 
human neutrophils in a 1:1 ratio, and examined 
microscopically after 1.5 h. The ratio of GFP 
expression in phagocytosed to non-phagocy-
tosed C. albicans cells was measured (C). Cor-
responding light and ﬂuorescence micrographs 
of phagocytosed C. albicans cells (neutrophils), 
and light and ﬂuorescence micrographs of con-
trol cells in plasma alone (plasma) are shown: 
bars represent 10 µm. Fold induction was mea-
sured by comparing the mean ﬂuorescence 
intensity for phagocytosed cells with that for 
non-phagocytosed C. albicans cells (n > 50). 
C. albicans strains containing PFK2-, PYK1-, 
PCK1- or ICL1-GFP fusions were compared 
with the control carrying the empty vector, 
pGFP (CJB-1, CJB-2, CJB-3, CLM1-1, 
CLM3-2: Table 1).
B. Cultured murine J774A-1 macrophages 
were mixed with C. albicans cells in a 1:1 ratio 
and analysed after 3 h, as described in A: 
phagocytosed C. albicans cells (macroph-
ages); non-phagocytosed cells (medium). 
Scale bar represents 20 µm.
C. Fold induction of GFP ﬂuorescence in 
phagocytosed cells versus non-phagocytosed 
cells in neutrophils and macrophages 
respectively.966 C. J. Barelle et al.
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The growth phenotype of each mutant was examined in
vitro (Fig. 5). As expected the pyk1/pyk1 mutant did not
grow  on glucose, but grew on non-fermentable carbon
sources. The pck1/pck1 mutant displayed growth defects
on non-fermentable carbon sources, but grew on glucose.
As expected (Lorenz and Fink, 2001), the icl1/icl1 mutant
did not grow on acetate, but grew on the other carbon
sources. These phenotypes were suppressed by the rein-
troduction of the corresponding wild-type gene (Fig. 5).
The virulence of these C. albicans  mutants and the
control reintegrant strains was then tested in the mouse
model of systemic candidiasis (MacCallum and Odds,
2005). The icl1/icl1 and pck1/pck1 cultures were prepared
in NGY medium, which contains glucose. However, the
pyk1/pyk1 mutant did not grow on glucose (Fig. 5), and
therefore this strain was grown on a derivative of NGY
medium containing amino acids instead of glucose. Con-
trol experiments, in which the parental and reintegrant
(pyk1/pyk1/PYK1) strains were prepared under identical
conditions, conﬁrmed that this change had a minimal
effect upon the virulence of C. albicans (Fig. 6).
Several observations were made in the virulence
assays. First, the inactivation of ICL1 did attenuate the
virulence of C. albicans, albeit partially, and this defect
was suppressed by the reintroduction of the ICL1 gene
(Fig. 6A). This conﬁrms the original study of Lorenz and
Fink (2001), which showed that the glyoxylate cycle (or at
least the ICL1 gene itself) is required for normal levels of
virulence in C. albicans.  Second, the C. albicans  pck1/
pck1  and  pyk1/pyk1  mutants also displayed attenuated
virulence, and these defects were suppressed by the rein-
troduction of the wild-type PCK1 or PYK1 genes respec-
tively (Fig. 6A). Hence these glycolytic and gluconeogenic
genes are also required for the virulence of C. albicans.
Third, there was a strong correlation between the viru-
lence data and the corresponding fungal burdens
observed in the tissues of infected animals (Fig. 6B). This
lends weight to conclusions relating to the relative effects
of the gene knockouts upon virulence. Four, the degree
of virulence attenuation was signiﬁcantly greater for pyk1/
pyk1 cells than for icl1/icl1 or pck1/pck1 cells. The inacti-
Fig. 4. Differential regulation of PFK2-, 
PYK1-, PCK1- and ICL1-GFP fusions in 
C. albicans in the kidney during systemic 
candidiasis.
A. Corresponding GFP (green) and Calcoﬂuor 
White-stained (blue) images of C. albicans cells 
infecting the mouse kidney. C. albicans strains 
containing PFK2-, PYK1-, PCK1- or ICL1-GFP 
fusions were compared with the control strain 
carrying the empty vector, pGFP (CJB-1, CJB-
2, CJB-3, CLM1-1, CLM3-2: Table 1).
B. Proportion of C. albicans cells (n > 1000) 
infecting the kidney that display GFP ﬂuores-
cence above background levels, in animals 
displaying clinical signs of infection.
Fig. 5. Growth of C. albicans pyk1/pyk1, pck1/pck1 and icl1/icl1 null 
mutants on different carbon sources. C. albicans wild type, pyk1/pyk1, 
pck1/pck1 and icl1/icl1 strains (wt, CLM19-3; pyk1, CLM44-5; pck1, 
CLM56-4; icl1, CLM25-5: Table 1) and the corresponding control 
strains containing a reintegrated copy of the wild-type gene 
(pyk1 + PYK1, CLM45-9; pck1 + PCK1, CLM57-2; icl1 + ICL1, 
CLM26-1: Table 1) were grown on minimal medium containing 2% 
glucose (Glu), 2% amino acids (AAs) or 2% acetate as sole carbon 
source.Regulation of carbon assimilation by C. albicans 967
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vation of PCK1 or ICL1 did attenuate virulence (Fig. 6A),
but did not prevent fungal growth in the host (Fig. 6B). We
conclude that neither gluconeogenesis nor the glyoxylate
cycle is essential for C. albicans  to thrive in the host.
However, glycolysis is important for the development of a
systemic infection.
Discussion
Our data conﬁrm and reinforce previous observations
relating to the role of the glyoxylate cycle, and the ICL1
gene in particular, in C. albicans pathogenesis. However,
we  have signiﬁcantly extended these observations by
describing the relative contributions of glycolysis and glu-
coneogenesis to the development of systemic candidiasis,
and by providing signiﬁcant insights into the heteroge-
neous behaviour of C. albicans  cells within complex
micro-environments in its mammalian host.
Several transcript proﬁling studies have indicated that
C. albicans  glyoxylate cycle genes (ICL1, MLS1) are
induced following exposure to host defences (Fradin et al.,
2003; 2005; Lorenz et al., 2004). This was the case fol-
lowing exposure to macrophages, which play an important
defensive role during infections of parenchyma, and to
neutrophils, which kill fungal cells present in the blood-
stream. As a large proportion of C. albicans cells in these
samples had been phagocytosed by the mammalian cells,
it was presumed that the fungal glyoxylate cycle genes
were induced after phagocytosis rather than in response
to cell-cell contact. Our data support the view that these
genes are induced after phagocytosis, when the fungal
cells enter an environment relatively free of glucose
(Fig. 3).
The inactivation of ICL1 has  been reported to be
required for fungal virulence (Lorenz and Fink, 2001).
However,  C. albicans  ICL1  was strongly repressed in
response to low levels of glucose (0.1%: Fig. 2) that are
equivalent to those found in the bloodstream in humans
and mice. Furthermore, although the gene is induced
following phagocytosis (Fig. 3), it is not expressed in most
C. albicans cells infecting the kidney (Fig. 4). How then
can  ICL1  be required for the development of systemic
infections? Several possible explanations might account
for this apparent paradox. First, the interpretation of the
C. albicans  virulence assays performed by Lorenz and
Fink (2001) might have been compromised by URA3 posi-
tion effects that were described after their ﬁndings were
published (Sundstrom et al., 2002; Brand et al., 2004;
Sharkey et al., 2005). We have shown that this is not the
case by testing the virulence a new homozygous icl1/icl1
mutant alongside appropriate controls that excluded
potential  URA3  position effects (Fig.  4). Second, ICL1
might contribute to the virulence of C. albicans  without
being essential for the establishment of systemic infec-
tions. We show that this is the case. ICL1 is required for
normal levels of C. albicans virulence. However, the viru-
lence of C. albicans icl1/icl1 cells is only partially attenu-
ated, and these cells are capable of establishing lethal
systemic infections, albeit more slowly than wild-type cells
(Fig. 6).
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Fig. 6. Virulence of C. albicans pyk1/pyk1, 
pck1/pck1 and icl1/icl1 null mutants in the 
mouse model of systemic infection.
A. Survival of immunocompetent female BALB/
c mice following tail vein injection of C. albicans 
cells: open squares, ﬁrst control representing 
the parental strain, RM1000 containing CIp20 
(CLM19-3: Table 1); closed circles, experiment 
representing the homozygous null mutant con-
taining CIp20 (icl1/icl1, CLM25-5; pck1/pck1, 
CLM56-4; pyk1/pyk1, CLM44-5: Table 1); open 
circles, second control representing the null 
mutant containing CIp20 and the wild-type 
gene (ICL1, CLM26-1; PCK1, CLM57-2; PYK1, 
CLM45-9: Table 1).
B. Tissue burdens in mouse organs infected 
with the same C. albicans strains. Fungal col-
ony forming units per gram of tissue were mea-
sured in the left kidney (black), right kidney 
(grey) and brain (white).968 C. J. Barelle et al.
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How might ICL1 contribute to C. albicans virulence with-
out being essential for the establishment of systemic infec-
tions? The transcript proﬁling and GFP data indicate that
ICL1  is induced following phagocytosis (Fig.  3: Lorenz
et al., 2004; Fradin et al., 2005). Therefore, the glyoxylate
cycle might help to protect C. albicans against host anti-
microbial defences by facilitating anabolic metabolism in
the absence of fermentable carbon sources (Lorenz and
Fink, 2002). The absence of a functional glyoxylate cycle
might lead to a reduction in the number of viable fungal
cells that are capable of colonizing host tissues. Also,
ICL1 might contribute to the growth of some fungal cells
at infection sites (Fig. 4).
The same rationale might apply to the PCK1 gene and
gluconeogenesis. Like ICL1, PCK1 was induced following
phagocytosis (Fig.  3: Lorenz et al., 2004; Fradin et al.,
2005). Like the C. albicans icl1/icl1 strain, the virulence of
the  pck1/pck1  mutant was partially attenuated in the
mouse model of systemic candidiasis. C. albicans pck1/
pck1 cells are unable to generate the ﬁve and six carbon
sugars required for the biosynthesis of cell wall and
nucleic acids, for example, from two or three carbon sub-
strates (Fig. 1), and hence were unable to grow on such
carbon sources (Fig. 5). Therefore, the fact that the icl1/
icl1 and pck1/pck1 mutants are able to colonize kidney
tissue (Fig.  6) indicates that, while growing in vivo,
C. albicans depends mainly upon the assimilation of fer-
mentable carbon sources in vivo, such as blood glucose
for example. This idea is reinforced by the observation
that pyk1/pyk1 cells are avirulent (Fig. 6), indicating that
C. albicans  depends upon glycolysis for growth in the
host. Hence in principle, some drugs that inhibit fungal
glycolytic enzymes without affecting their mammalian
counterparts could prove to be effective antifungal
agents.
Our analyses of GFP fusions have provided direct evi-
dence for a high degree of metabolic heterogeneity within
fungal cell populations in vivo  (Fig.  4). Almost all
C. albicans  cells infecting the mouse kidney expressed
the PFK2- and PYK1-GFP fusions, indicating that most of
these fungal cells were actively growing, or had recently
been actively growing. [The half-life of GFP in growing
C. albicans is about 1.5 h (Barelle et al., 2004)] However,
fewer than half of these cells expressed the PCK1- and
ICL1-GFP fusions (Fig. 4). This implies that, while most
cells were assimilating carbon via the glycolytic pathway,
some had switched to gluconeogenic metabolism. There-
fore, glucose appears to become limiting in some micro-
environments within the infected kidney. Currently meth-
ods are being developed for the transcript proﬁling of
C. albicans cells isolated from infected tissues. The het-
erogeneity of fungal populations within foci of infection has
major implications for the interpretation of these transcript
proﬁling data sets.
In conclusion, our data reveal that the pathogen
C. albicans  regulates central carbon metabolism in a
niche-speciﬁc manner during disease establishment and
progression. During the early stages of a systemic infec-
tion, C. albicans activates the glyoxylate cycle and gluco-
neogenesis in response to phagocytosis. In the latter
stages of an infection, when the fungus is colonizing tis-
sue, glycolytic metabolism predominates. Presumably,
this increases the biological ﬁtness of this pathogen within
its host.
Experimental procedures
Strains and growth conditions
Candida albicans strains  (Table 1) were grown in YPD or syn-
thetic complete medium (Sherman, 1991; Kaiser et al., 1994) or
in minimal medium (0.67% Yeast Nitrogen Base) containing 2%
glucose, 2% casamino acids or 2% acetate as sole carbon
source.
Strain construction
The plasmids pGFP and pPCK1-GFP have been described pre-
viously (Barelle et al., 2004). To generate pICL1-GFP, the
CaICL1 promoter region (−983 to −1, relative to the start codon)
was PCR-ampliﬁed using the primers ICL1-5′ and ICL1-3′, and
cloned between the XhoI and HindIII sites of pGFP. To make
pPYK1-GFP, the CaPYK1 promoter region (−1576 to −3) was
PCR-ampliﬁed using the primers PYK5′-2 and PYK3′-3, and
cloned between the BstEII and MluI sites of pGFP. To produce
pPFK2-GFP, the CaPFK2  promoter region (−992 to −1) was
PCR-ampliﬁed using primers PFK2-5′ and PFK2-3′ and cloned
between the XhoI and HindIII sites of pGFP. These plasmids
were linearized with StuI and integrated at the RPS1 locus in
C. albicans CAI4 (Murad et al., 2000). The genotypes of trans-
formants were conﬁrmed by PCR and Southern blotting, as
described previously (Barelle et al., 2004).
The C. albicans pyk1/pyk1 null mutant was constructed using
the parental strain RM1000 (Table  1). Each PYK1  allele was
inactivated sequentially with loxP-URA3-loxP ( LUL) and loxP-
HIS1-loxP ( LHL) disruption cassettes (Dennison et al., 2005)
generated by PCR ampliﬁcation with the oligonucleotide primers
PYK-L1 and PYK-L2  (Table 2). The pyk1::LUL and pyk1::LHL
disruption cassettes contained about 65 bp of homology to the
5′ and 3′ ends of the PYK1 locus, and deleted codons 19–490
of the PYK1 open reading frame. The pyk1::LUL cassette was
transformed into RM1000, transformants selected on the basis
of their uridine protrophy, and integration at the correct locus
conﬁrmed by PCR diagnosis with the primers PYK-5′-DIAG and
URA3-REV-DIAG (Table  2), as described previously (Wilson
et al., 1999). The resultant heterozygote (pyk1::loxP-URA3-loxP/
PYK1: PD24) was then transformed with the pyk1::LHL cassette,
and the introduction of this allele and the removal of the last wild-
type PYK1 allele from the C. albicans genome was conﬁrmed by
PCR using the primer PYK-5′-DIAG with HIS1-REV-DIAG or
PYK-IP, respectively (Table 2), thereby generating the homozy-
gous null mutant, CLM5-1 (Table 1).Regulation of carbon assimilation by C. albicans 969
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Table 1. C. albicans strains.
Strain Genotype Parent Source
SC5314 Wild type Gillum et al. 1984
CAF2-1 URA3/ura3::λ imm434 SC5314 Fonzi and Irwin (1993)
CAI4 ura3::λ imm434/ura3::λ imm434 CAF2-1 Fonzi and Irwin (1993)
CJB-1 ura3::λ imm434/ura3::λ imm434, pGFP CAI4 Barelle et al. (2004)
CJB-2 ura3::λ imm434/ura3::λ imm434, pPCK1-GFP CAI4 Barelle et al. (2004)
CJB-3 ura3::λ imm434/ura3::λ imm434, pICL1-GFP CAI4 This study
CLM1-1 ura3::λ imm434/ura3::λ imm434, pPYK1-GFP CAI4 This study
CLM3-2 ura3::λ imm434/ura3::λ imm434, pPFK2-GFP CAI4 This study
RM1000 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG CAI4 Wilson et al. (1999)
CLM19-3 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, CIp20 (URA3, HIS1) RM1000 This study
CLM4-10 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, ICL1/icl1::URA3 RM1000 This study
CLM18-1 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, icl1::HIS1/icl1::URA3 RM1000 This study
CLM21-1 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, icl1::HIS1/icl1::ura3 RM1000 This study
CLM25-5 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, icl1::HIS1/icl1::ura3, CIp20 (URA3, 
HIS1)
RM1000 This study
CLM26-1 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, icl1::HIS1/icl1::ura3, CIp20-ICL1 RM1000 This study
CLM17-1 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, PCK1/pck1::URA3 RM1000 This study
CLM53-1 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, pck1::HIS1/pck1::URA3 RM1000 This study
CLM54-1 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, pck1::HIS1/pck1::ura3 RM1000 This study
CLM56-4 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, pck1::HIS1/pck1::ura3, CIp20 (URA3, 
HIS1)
RM1000 This study
CLM57-2 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, pck1::HIS1/pck1::ura3, CIp20-PCK1 RM1000 This study
PD24 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, PYK1/pyk1::URA3 RM1000 This study
CLM5-1 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, pyk1::HIS1/pyk1::URA3 RM1000 This study
CLM29-2 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, pyk1::HIS1/pyk1::ura3 RM1000 This study
CLM44-5 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, pyk1::HIS1/pyk1::ura3, CIp20 (URA3, 
HIS1)
RM1000 This study
CLM45-9 ura3::λ imm434/ura3::λ imm434, his1::hisG/his1::hisG, pyk1::HIS1/pyk1::ura3, CIp20-PYK1 RM1000 This study
Table 2. Oligonucleotides.
Primer Sequence (5′ to 3′) Use
ICL1-5′ CCCTCGAGGTCATGGAATCG Cloning of ICL1 promoter (XhoI site underlined)
ICL1-3′ GGAAGCTTTTATTAATGTTTATTC Cloning of ICL1 promoter (HindIII site underlined)
PYK5′-2 CCCTCGAGTATAGAAATTGGGTTGC Cloning of PYK1 promoter (XhoI site underlined)
PYK3′-3 AAACTGCAGTGATGTAGTTTGTAGG Cloning of PYK1 promoter (PstI site underlined)
PFK2-5′ CCGCTCGAGATTCTATGACGTGGGT Cloning of PFK2 promoter (XhoI site underlined)
PFK2-3′ CCCAAGCTTGGTGGTTGTTTTTCGT Cloning of PFK2 promoter (HindIII site underlined)
ICL1-L1 TCCGGATGGCAATGTTCTTCTACTGCTTCCACTTCTAACGAACC
ATCTCCAGATTTGGCTCCAGGGTTTTCCCAGTCACG
PCR ampliﬁcation of icl1 disruption cassettes 
(homology to pLHL and pLUL plasmids underlined)
ICL1-L2B CTTGATGTAAGTTTCTTGTTCGTCAGCTGGCATGGCCTTGTTCCA
GTTGAAAGATGGAGACTCACTAAAGGGAACAAAAGC
PCR ampliﬁcation of icl1 disruption cassettes
(homology to pLHL and pLUL plasmids underlined)
ICL1-IP TTCTGGGTTAGTGGCACCAA Diagnosis of icl1 alleles, internal 3’ primer
ICL1-5′-DIAG CAGGTGAAGAGTCACTTCTA Diagnosis of icl1 alleles, upstream primer
PCK-L1 AAATAATTATCAATCATGGCTCCTCCTACTGCTGTTGAATCTTCAA
TCAATTTCGGAGGTCACCCAGGGTTTTCCCAGTCACG
PCR ampliﬁcation of pck1 disruption cassettes
(homology to pLHL and pLUL plasmids underlined)
PCK1-L2 GACAATTCACCAGAGTGGATAGCATCCAAGATAGCTCTGGTGTA
TTTCAATGGACATCTCACTAAAGGGAACAAAAGC
PCR ampliﬁcation of pck1 disruption cassettes
(homology to pLHL and pLUL plasmids underlined)
PCK-5′-DIAG GACATCACCTTTTTCAACC Diagnosis of pck1 alleles, internal 3’ primer
PCK-IP CAACAATACCGTCAACTC Diagnosis of pck1 alleles, upstream primer
PYK-L1 CTACATCAACAATGTCTCACTCATCTTTATCTTGGTTATCCAA
CTTCAATGTTGAAACTGTTCCAGGGTTTTCCCAGTCACG
PCR ampliﬁcation of pyk1 disruption cassettes
(homology to pLHL and pLUL plasmids underlined)
PYK-L2 ATCAAGGCTTCTTTTCCACTTAAGCTTGGACGATTCTAACAGTG
TTAGAGTGACCAGAACCTCACTAAAGGGAACAAAAGC
PCR ampliﬁcation of pyk1 disruption cassettes 
(homology to pLHL and pLUL plasmids underlined)
PYK-IP TCCTTACCTTCTTCACC Diagnosis of pyk1 alleles, internal 3’ primer
PYK-5′-DIAG TTAGAAAGGAAACAAAGGG Diagnosis of pyk1 alleles, upstream primer
HIS1-REV-DIAG CACAAGAAGCCTCAACGG Diagnosis of LHL alleles, downstream primer
URA3-REV-DIAG TAGTGTTACGAATCAATGGC Diagnosis of LUL alleles, downstream primer
ICL1-CIp20-5′ CCATCGATCAAAAACTTAATTTAACCAGCG Cloning of ICL1 locus (ClaI site underlined)
ICL1-CIp20-3′ CGACGCGTTAAAGGCTCAAATTGTTCCCG Cloning of ICL1 locus (MluI site underlined)
PYK-CIp20-5′ CCATCGATTATAGAAATTGGGTTGC Cloning of PYK1 locus (ClaI site underlined)
PYK-CIp20-3′ CGACGCGTGCAGAATTAACGTATG Cloning of PYK1 locus (MluI site underlined)
PCK-CIp20-5′ CCATCGATTTGGTCCATTGCCGT Cloning of PCK1 locus (ClaI site underlined)
PCK-CIp20-3′ CGACGCGTCCATAGGATTATGAGAC Cloning of PCK1 locus (MluI site underlined)970 C. J. Barelle et al.
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To generate the prototrophic reintegrant strain CLM45-9 (pyk1/
pyk1/PYK1), ura3
– segregants were selected on YPD containing
1 mg ml
−1 5- ﬂuoroorotic acid (Fonzi and Irwin, 1993), generating
the strain CLM29-2. The plasmid CIp20-PYK1 was then trans-
formed into CLM29-2, selecting for the URA3 marker, to create
the strain CLM45-9. CIp20-PYK1 contained the PYK1 locus from
coordinates −1576 upstream from the start codon to +354 down-
stream from the stop codon, and was generated using primers
PYK-CIp20-5′  and PYK-CIp20-3′  (Table  2). As a control, the
empty CIp20 vector was transformed into CLM29-2, to create
CLM44-5 (Table 1). CIp20-based plasmids, which contain both
URA3 and HIS1 markers, were integrated at the RPS1 locus, and
correct integration conﬁrmed by PCR diagnosis (Dennison et al.,
2005).
Congenic  C. albicans  icl1/icl1  and  pck1/pck1  null mutants
(CLM18-1 and CLM53-1, respectively: Table 1) were constructed
using the same approach. In the icl1/icl1 mutants, codons 121–
430 of the ICL1 open reading frame were deleted. In the pck1/
pck1 mutants, codons 18–459 of the PCK1 open reading frame
were deleted. Reintegrant and control strains were generated, as
described above (Table 1). CIp20-ICL1 contained the ICL1 locus
from −999 upstream from the start codon to +367 downstream
from the stop codon, and CIp20-PCK1 contained the PCK1 locus
from −977 to +500. The genotypes of all strains were conﬁrmed
by Southern blotting, as well as by PCR (Dennison et al., 2005).
DNA manipulations
Cloning, PCR ampliﬁcation and Southern analysis were per-
formed as described previously (Sambrook et al., 1989; Denni-
son et al., 2005).
Proteomics
Protein extracts were prepared from mid-exponential C. albicans
CLM19-3 cells (Table 1) growing on 2% glucose, casamino acids,
lactate or oleic acid as sole carbon source. Extracts were also
prepared 2 h after the addition of 0.1% glucose to cultures grow-
ing on 2% casamino acids, lactate or oleic acid. Protein extracts
were subjected to 2D-gel electrophoresis, and the spots corre-
sponding to the Pfk2, Pyk1, Pck1 and Icl1 proteins identiﬁed by
peptide mass ﬁngerprinting (Yin et al., 2004). The relative level
of each protein was measured by determining their mean spot
volumes under each of the growth conditions in three indepen-
dent replicate experiments.
Microscopy
Fungi were stained with Calcoﬂuor White as described previ-
ously (Gow and Gooday, 1982). Nuclei were stained by overlay-
ing mounting media containing DAPI (Vector Laboratories,
Peterborough, UK). For phase contrast and ﬂuorescence micros-
copy an Axioplan 2 microscope (Carl Zeiss, UK) was used with
ﬁlter sets; XF 66, XF 67 and XF 77 (Omega Optical, Brattleboro,
VT). Images were generated with a Hamamatsu CCD camera,
and analysed with Openlab 3.0.9 software (Improvision, Coven-
try, UK). Relative GFP ﬂuorescence intensities were quantiﬁed
for individual yeast cells or hyphal compartments by measure-
ment of regions of interest. Mean ﬂuorescence intensities
(± standard deviation) were then calculated for at least 50 indi-
vidual cells, as described before (Barelle et al., 2004). GFP ﬂu-
orescence levels never exceeded the quantitative range of the
assay.
Ex vivo analysis of C. albicans
Neutrophils were isolated from human blood (Fradin et al., 2005),
C. albicans cells mixed with them in a 1:1 ratio, and GFP ﬂuo-
rescence measured after 1.5  h (Barelle et al., 2004). Murine
J774A-1 macrophages (Ralph et al., 1975) were mixed with
C. albicans cells in a 1:1 ratio and analysed after 3 h. The ratio
of GFP expression in phagocytosed to non-phagocytosed
C. albicans cells was measured. Fold induction was measured
by comparison of mean ﬂuorescence intensity for phagocytosed
cells with that for non-phagocytosed C. albicans cells (n > 50).
Murine model of systemic candidiasis
Immunocompetent female BALB/c mice (Harlan Sera-lab, Lough-
borough, UK) were challenged intravenously with C. albicans.
The C. albicans icl1/icl1 and pck1/pck1 strains and their controls
(CLM19-3, CLM25-5, CLM26-1, CLM56-4 and CLM57-2:
Table 1) were grown with shaking for 18–24 h at 30°C in NGY
medium (0.1% Neopeptone, 0.4% glucose and 0.1% Yeast
Extract). The pyk1/pyk1 null mutant and its controls (CLM44-5,
CLM45-9 and CLM19-3: Table 1) were grown on NGY containing
0.4% Casamino acids instead of glucose. Groups of ﬁve or six
mice were inoculated via the lateral tail vein with 1.2–
1.9 × 10
4 cfu per gram of body weight (Brand et al., 2004; Mac-
Callum and Odds, 2005). Mice were monitored over 28 days and
animals showing signs of distress or illness were humanely ter-
minated and deaths recorded as occurring the following day. The
kidneys and brain were removed post mortem, homogenized in
0.5 ml of water, and C. albicans tissue burdens determined by
viable counting. Viable counts were performed on glucose-con-
taining medium for the icl1/icl1 and pck1/pck1 mutants, and on
amino acid-containing medium for the pyk1/pyk1 mutant. For the
analysis of GFP expression in vivo, frozen sections of kidney
tissue from infected mice were examined as described previously
(Barelle et al., 2004). All experimentation was carried out under
the terms of the UK Home Ofﬁce licenses for research on
animals.
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